Home / Equities / Oppenheimer Equities Analysts Raise Earnings Estimates for UroGen Pharma Ltd. (NASDAQ:URGN)

Oppenheimer Equities Analysts Raise Earnings Estimates for UroGen Pharma Ltd. (NASDAQ:URGN)

Stock analysts at Oppenheimer increased their Q2 2022 EPS estimates for UroGen Pharma in a research report issued on Wednesday, May 11th. Oppenheimer analyst L. Gershell now expects that the company …
Read Full Story at source (may require registration)